Nadine Mc Leod
About Nadine Mc Leod
Nadine McLeod is an Associate Director at Wave Life Sciences, with extensive experience in clinical operations and trial management. She has held various roles in organizations such as Biogen and Analgesic Solutions, contributing to clinical trials across multiple phases.
Work at Wave Life Sciences
Nadine Mc Leod has been serving as an Associate Director at Wave Life Sciences since 2022. In this role, she is responsible for overseeing various aspects of clinical operations. Her work involves managing clinical trials and ensuring compliance with regulatory standards. Based in Lexington, Massachusetts, she has contributed to the company's mission of advancing innovative therapies.
Previous Experience at Biogen
Nadine Mc Leod worked at Biogen from 2017 to 2022. She held the position of Clinical Operations Lead from 2017 to 2019 and then served as Sr. Manager Clinical Trial Lead until 2022. During her tenure, she was involved in managing clinical trials and coordinating with various stakeholders to ensure the successful execution of clinical studies in Cambridge, Massachusetts.
Career at Analgesic Solutions
Nadine Mc Leod's career at Analgesic Solutions spanned multiple roles from 2015 to 2017. She began as a Clinical Trials Project Manager and progressed to Sr. Clinical Program Manager. In these positions, she managed clinical operations and oversaw trial execution. Her time at Analgesic Solutions provided her with significant experience in clinical trial management in Natick, Massachusetts.
Educational Background
Nadine Mc Leod holds a Master's degree in Public Health from The Dartmouth Institute for Health Policy & Clinical Practice, which she completed from 2008 to 2009. She also earned a Bachelor of Arts degree in Biology and Anthropology from Bennington College. Her educational background has equipped her with a solid foundation in health policy and clinical research.
Clinical Trial Management Expertise
Nadine Mc Leod possesses extensive experience in managing clinical trials from initiation to close-out. She has worked on various study phases, including Proof of Concept, Phase I, II, III, and Post-Market studies. Her expertise includes collaborating with clinical trial service providers, regulatory bodies, and managing monitoring activities and Clinical Research Associate (CRA) management.